A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation
Control of a biventricular assist device (BiVAD) is more challenging than control of a left ventricular assist device due to the process interactions between control loops in a multi-input-multi-output system. Hence, a single centralized multi-objective model predictive controller (CMO-MPC) has been...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Published: |
Elsevier Sci Ltd
2020
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/36725/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Universiti Malaya |
id |
my.um.eprints.36725 |
---|---|
record_format |
eprints |
spelling |
my.um.eprints.367252024-11-05T08:21:35Z http://eprints.um.edu.my/36725/ A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation Koh, V. C. A. Pauls, J. P. Wu, E. L. Stevens, M. C. Ho, Y. K. Lovell, N. H. Lim, E. Q Science (General) Medical technology Control of a biventricular assist device (BiVAD) is more challenging than control of a left ventricular assist device due to the process interactions between control loops in a multi-input-multi-output system. Hence, a single centralized multi-objective model predictive controller (CMO-MPC) has been developed to control a BiVAD. The CMO-MPC aims to: 1) adapt pump flow rate according to the Frank-Starling mechanism, 2) avoid ventricular suction, and 3) avoid vascular congestion. The CMO-MPC was benchmarked against a constant-speed (CS) setting in exercise, postural change, and systemic vascular resistance change tests in a mock circulation loop. The CMO-MPC increased pump flow rate from 5.0 L/min to 7.6 L/min in the exercise scenario, which was higher than the pump flow rate in the CS setting (6.0 L/min). In the postural change test, right ventricular end diastolic pressure (RVEDP) decreased to a minimum at 0.1 mmHg and 2.0 mmHg in the CS setting and the CMO-MPC, respectively, indicating that the CMO-MPC could minimize the risk of ventricular suction (with higher minimum RVEDP than the CS setting) when there was a sudden decrease in venous return. In all tests, the CMO-MPC could adapt pump flow rate without resulting events of ventricular suction and vascular congestion. (C) 2020 Elsevier Ltd. All rights reserved. Elsevier Sci Ltd 2020-05 Article PeerReviewed Koh, V. C. A. and Pauls, J. P. and Wu, E. L. and Stevens, M. C. and Ho, Y. K. and Lovell, N. H. and Lim, E. (2020) A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation. Biomedical Signal Processing and Control, 59. ISSN 1746-8094, DOI https://doi.org/10.1016/j.bspc.2020.101914 <https://doi.org/10.1016/j.bspc.2020.101914>. 10.1016/j.bspc.2020.101914 |
institution |
Universiti Malaya |
building |
UM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
Universiti Malaya |
content_source |
UM Research Repository |
url_provider |
http://eprints.um.edu.my/ |
topic |
Q Science (General) Medical technology |
spellingShingle |
Q Science (General) Medical technology Koh, V. C. A. Pauls, J. P. Wu, E. L. Stevens, M. C. Ho, Y. K. Lovell, N. H. Lim, E. A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation |
description |
Control of a biventricular assist device (BiVAD) is more challenging than control of a left ventricular assist device due to the process interactions between control loops in a multi-input-multi-output system. Hence, a single centralized multi-objective model predictive controller (CMO-MPC) has been developed to control a BiVAD. The CMO-MPC aims to: 1) adapt pump flow rate according to the Frank-Starling mechanism, 2) avoid ventricular suction, and 3) avoid vascular congestion. The CMO-MPC was benchmarked against a constant-speed (CS) setting in exercise, postural change, and systemic vascular resistance change tests in a mock circulation loop. The CMO-MPC increased pump flow rate from 5.0 L/min to 7.6 L/min in the exercise scenario, which was higher than the pump flow rate in the CS setting (6.0 L/min). In the postural change test, right ventricular end diastolic pressure (RVEDP) decreased to a minimum at 0.1 mmHg and 2.0 mmHg in the CS setting and the CMO-MPC, respectively, indicating that the CMO-MPC could minimize the risk of ventricular suction (with higher minimum RVEDP than the CS setting) when there was a sudden decrease in venous return. In all tests, the CMO-MPC could adapt pump flow rate without resulting events of ventricular suction and vascular congestion. (C) 2020 Elsevier Ltd. All rights reserved. |
format |
Article |
author |
Koh, V. C. A. Pauls, J. P. Wu, E. L. Stevens, M. C. Ho, Y. K. Lovell, N. H. Lim, E. |
author_facet |
Koh, V. C. A. Pauls, J. P. Wu, E. L. Stevens, M. C. Ho, Y. K. Lovell, N. H. Lim, E. |
author_sort |
Koh, V. C. A. |
title |
A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation |
title_short |
A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation |
title_full |
A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation |
title_fullStr |
A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation |
title_full_unstemmed |
A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation |
title_sort |
centralized multi-objective model predictive control for a biventricular assist device: an in vitro evaluation |
publisher |
Elsevier Sci Ltd |
publishDate |
2020 |
url |
http://eprints.um.edu.my/36725/ |
_version_ |
1814933263082323968 |